# Melatonin Mitigates Acidosis-Induced Neuronal Damage by Up-Regulating Autophagy via the Transcription Factor EB

**Authors:** Yan Shi, Zhaoyu Mi, Wei Zhao, Yue Hu, Hui Xiang, Yaoxue Gan, Shishan Yuan

PMC · DOI: 10.3390/ijms26031170 · 2025-01-29

## TL;DR

Melatonin protects neurons from acidosis by boosting autophagy through the movement of a key protein into the nucleus.

## Contribution

Melatonin's neuroprotective mechanism via TFEB-mediated autophagy in acidosis is newly identified.

## Key findings

- Acidosis reduces nuclear TFEB and suppresses autophagy, leading to neuronal damage.
- Melatonin promotes TFEB nuclear translocation and enhances autophagy, reversing neuronal apoptosis.
- Modulating TFEB confirms its role in melatonin's protective effects against acidosis.

## Abstract

Acidosis, a common feature of cerebral ischemia and hypoxia, results in neuronal damage and death. This study aimed to investigate the protective effects and mechanisms of action of melatonin against acidosis-induced neuronal damage. SH-SY5Y cells were exposed to an acidic environment to simulate acidosis, and a photothrombotic (PT) infarction model was used to establish an animal model of cerebral ischemia of male C57/BL6J mice. Both in vivo and in vitro studies demonstrated that acidosis increased cytoplasmic transcription factor EB (TFEB) levels, reduced nuclear TFEB levels, and suppressed autophagy, as evidenced by elevated p62 levels, a higher LC3-II/LC3-I ratio, decreased synapse-associated proteins (PSD-95 and synaptophysin), and increased neuronal apoptosis. In contrast, melatonin promoted the nuclear translocation of TFEB, enhanced autophagy, and reversed neuronal apoptosis. Moreover, the role of TFEB in melatonin’s neuroprotective effects was validated by modulating TFEB nuclear translocation. In conclusion, melatonin mitigates acidosis-induced neuronal damage by promoting the nuclear translocation of TFEB, thereby enhancing autophagy. These findings offer new insights into potential treatments for acidosis.

## Linked entities

- **Genes:** TFEB (transcription factor EB) [NCBI Gene 7942], DLG4 (discs large MAGUK scaffold protein 4) [NCBI Gene 1742]
- **Proteins:** TFEB (transcription factor EB), GTF2H1 (general transcription factor IIH subunit 1), Map1lc3a (microtubule-associated protein 1 light chain 3 alpha), Map1lc3a (microtubule-associated protein 1 light chain 3 alpha), DLG4 (discs large MAGUK scaffold protein 4)
- **Chemicals:** melatonin (PubChem CID 896)
- **Diseases:** cerebral ischemia (MONDO:0002679)

## Full-text entities

- **Genes:** SYP (synaptophysin) [NCBI Gene 6855] {aka MRX96, MRXSYP, XLID96}, MAP1LC3A (microtubule associated protein 1 light chain 3 alpha) [NCBI Gene 84557] {aka ATG8E, LC3, LC3A, MAP1ALC3, MAP1BLC3}, DLG4 (discs large MAGUK scaffold protein 4) [NCBI Gene 1742] {aka MRD62, PSD95, SAP-90, SAP90}, TFEB (transcription factor EB) [NCBI Gene 7942] {aka ALPHATFEB, BHLHE35, TCFEB}, NUP62 (nucleoporin 62) [NCBI Gene 23636] {aka IBSN, SNDI, p62}
- **Diseases:** cerebral ischemia (MESH:D002545), neuronal apoptosis (MESH:D065703), Acidosis (MESH:D000138), hypoxia (MESH:D000860), Neuronal Damage (MESH:D009410), infarction (MESH:D007238)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** SH-SY5Y — Homo sapiens (Human), Neuroblastoma, Cancer cell line (CVCL_0019)

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11818126/full.md

---
Source: https://tomesphere.com/paper/PMC11818126